Familial hypocalciuric hypercalcemia: new mutation in the CASR gene converting valine 697 to methionine.
Article Details
- CitationCopy to clipboard
Aparicio Lopez C, Anton-Martin P, Gil-Fournier B, Ramiro-Leon S, Perez-Nanclares G, Perez de Nanclares G, Martinez Menendez B, Castano L
Familial hypocalciuric hypercalcemia: new mutation in the CASR gene converting valine 697 to methionine.
Eur J Pediatr. 2012 Jan;171(1):147-50. doi: 10.1007/s00431-011-1504-8. Epub 2011 Jun 4.
- PubMed ID
- 21643651 [ View in PubMed]
- Abstract
Familial hypocalciuric hypercalcemia is an uncommon cause of hypercalcemia that arises from mutations in the calcium-sensing receptor gene. Inactivation of this receptor leads to a decreased receptor sensitivity to calcium, determining that higher concentrations of calcium are needed to inhibit the release of parathormone in the parathyroid glands. Patients usually are asymptomatic. Diagnosis is usually made casually after a routine blood analysis. The syndrome is characterized by mild or moderate hypercalcemia, hypocalciuria, and normal or slightly increased levels of parathormone. The degree of hypercalcemia depends on the type of mutation. The accurate diagnosis is important since it is a benign disorder that does not require medical or surgical treatment. We report a 9-year-old female with persistent hypercalcemia in several routine blood analyses, who was diagnosed with familial hypocalciuric hypercalcemia after genetic studies were performed. A new mutation determining a nucleotide change c.2089G>A in the calcium-sensing receptor gene (exon 7) was detected. This mutation was also found in the patient's mother and brother.